Hypertension and Postoperative Pain: A Prospective Observational Study

Table 3

Comparisons of postoperative outcomes in male patients unadjusted and adjusted for age and weight ().

		Normotensive ()	H/T without M ()	H/T with M ()	value	Adjusted value
POD1	VASM1	4.3 ± 1.1	5.0 ± 1.9^‡	3.7 ± 1.3	0.007^∗	0.015^!
	VASR1	1.8 ± 1.1	2.3 ± 1.7^‡	1.3 ± 1.1	0.042^∗	0.038^!
	DOSE1 (mL)	86.7 ± 62.0	77.9 ± 41.3	72.9 ± 35.9	0.651	0.919
	PONV1	0 (0%)	1 (2.5%)	2 (7.1%)
POD2	VASM2	3.3 ± 1.0	3.9 ± 1.6	3.2 ± 1.5	0.133	0.032!
	VASR2	1.2 ± 0.8	1.3 ± 1.2	0.9 ± 1.1	0.401	0.362
	DOSE2 (mL)	114.5 ± 84.0	133.7 ± 62.8	135.9 ± 66.0	0.888	0.761
	PONV2	0 (0%)	0 (0%)	0 (0%)
POD3	VASM3	2.2 ± 1.3	3.1 ± 1.7	2.5 ± 1.1	0.273	0.085
	VASR3	0.6 ± 0.6	0.7 ± 0.8	0.5 ± 0.5	0.476	0.578
	DOSE3 (mL)	171.0 ± 101.6	164.7 ± 83.1	169.6 ± 82.2	0.961	0.564
	PONV3	0 (0%)	0 (0%)	0 (0%)

Data are presented as mean ± SD or number (%). POD1: postoperative day 1; POD2: postoperative day 2; POD3: postoperative day 3; PONV: postoperative nausea and vomiting; VASM: analogue scales on movement; VASR: analogue scales at rest; DOSE: postoperative morphine consumption (0.4 mg/mL). Unadjusted for independent-samples, one-way ANOVA. ^!Adjusted for independent-samples, one-way ANCOVA (age and weight as covariates). ^‡Adjusted when comparing the H/T without medication and H/T with medication groups.